Shuang Liu, based in Princeton, New Jersey, United States, is currently a CEO and Founder at ConSynance Therapeutics, Inc., bringing experience from previous roles at ConSynance Therapeutics, Inc. and AMRI. Shuang Liu holds a 1997 - 1998 Post Doctoral Training in Organic Chemistry @ Emory University. With a robust skill set that includes Organic Synthesis, Medicinal Chemistry, Organic Chemistry, Drug Development, Drug Design and more, Shuang Liu contributes valuable insights to the industry. Shuang Liu has 2 emails and 1 mobile phone number on RocketReach.